BIIB Initiated With Buy At Soleil

Symbols: BIIB
Tags: Soleil
Share

Analysts at Soleil Securities Group initiate coverage of Biogen Idec (NASDAQ: BIIB) with a "buy" rating. The target price for BIIB is set to $70.

BIIB’s shares closed at $57.67 yesterday. More Analyst Ratings here


 
 
< Previous
LNCE Upgraded To Buy At BB&T
Next >
Dick's Sporting Goods (DKS) Reports $67.4 Million Net Income
Share
Printer-friendly version
Send to friend
We're Loving

Benzinga's Premium Memberships

Benzinga's News Delivered Free

Brain Trust

Special Offers:
Quick Cash Advance